There are items in your quote.

Continue shopping Go to quote detail

Rabbit anti-CDK9 Antibody, Affinity Purified

Catalog No.
A303-493A-M
Pack Size
  • 20 µl (2 blots)
  • 100 µl (10 blots)
  • 100 µl (200 µg/ml)
Quantity
Add To Wishlist
Add to wishlist

* Free Delivery for Orders SGD$250 (excl. GST) & Above.

Brand:
Specifications
A303-493A-M
Brand
Bethyl Laboratories
Application
IHC
IP
WB
Storage Conditions
2 - 8° C
Host
Rabbit
Conjugation
Unconjugated
Immunogen
Between 322 and 372
Buffer
Tris-buffered Saline containing 0.1% BSA and 0.09% Sodium Azide
Reactivity
Human, Mouse
Target
CDK9
Shelf Life
1 year from date of receipt
Antibody Type
Polyclonal
Alternate Names
C-2k, CDC2L4, CDC2-related kinase, cell division cycle 2-like protein kinase 4, cell division protein kinase 9, CTK1, cyclin-dependent kinase 9, PITALRE, serine/threonine protein kinase PITALRE, Serine/threonine-protein kinase PITALRE, TAK, tat-associated kinase complex catalytic subunit
Format
Whole IgG
Presumed Reactivity
Based on 100% sequence identity, this antibody is predicted to react with Rat and Bovine
Product Type
Primary Antibodies
Product Sub Types
Primary Antibodies
UNSPSC
12352203
Western Blot (WB)
1:2,000 - 1:10,000
Immunoprecipitation (IP)
2 - 10 µg/mg lysate
Immunohistochemistry (IHC)
1:100 - 1:500. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
Target Sentence
Cyclin-dependent kinase 9 (CDK9) is a member of the CDK family of kinases and a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. CDK9 forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K.
Product Link
http://www.bethyl.com/product/A303-493A
Reviews
No comments
Related products
Close
More results
No products were found.

 

My Account

Create a free account to save loved items.

Sign in

Create a free account to use wishlists.

Sign in